McKesson (MCK) Shares Jump as Analyst Upgrades to Outperform

Shares of McKesson (NYSE: MCK) are feeling a boost today on the back of a Raymond James upgrade. The firm moved its investment rating on McKesson from Market Perform to Outperform. The stock most recently traded at $44.94, up 3.3% from yesterday's close.

The upgrade follows news yesterday morning that McKesson has renewed a pharmaceutical distribution agreement with CVS Caremark (NYSE: CVS).

To stay up-to-date on all the analyst calls on McKesson, visit our Analyst Ratings page.

McKesson Corporation, together with its subsidiaries, provides supply, information, and care management products and services for the healthcare industry.

You May Also Be Interested In

• Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
• Morgan Stanley Upgrades Ternium S.A. (TX) to Overweight
• Morgan Stanley Upgrades Megaport Ltd. (MP1:AU) (MGPPF) to Overweight